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Abstract 
Background: Rare cases if CMV retinitis were presented in immunocompetent patients (Nine cases) 
Cases Report: A 23 years old man with chief complain of sudden decrease of visual acuity and floater in left 
eye was under investigation. He was immunocompetent patient without any human immunodeficiency virus 
and immunosuppression diseases. He was diagnosed as a case of cytomegalovirus retinitis and was treated by 
intraviteral Ganciclovir. His choroid retinitis was improved after treatment. 
Conclusion: in retinal vasculitis before approaching anti-inflammatory or anti-VEGF therapy 
ophthalmologists should take into account infectious causes. 
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Cytomegalovirus retinitis (CMVR) has been the most 
common opportunistic ocular infection and the 
loading cause of visual loss among acquired 
immunodeficiency syndrome (AIDS) patients with 
representing about 90% case of all infectious retinitis 
in this population1,2, but rare case reports were 
presented in immunocompetent patients (Nine 
cases)3. Despite its well characterized clinical course 
and multitude of high quality studies for the 
diagnosis and treatment of this disease CMVR is 
described with visual loss, flashing, flouters and 
conjunctivitis. CMV-PCR and ophthalmoscopy help 
to diagnosis4. 
Case Report 
A 23 year-old man from Ardakan, Yazd province, in 
Iran with the chief complain of sudden decrease of 
visual acuity is considered. He states that a flouter in 
his left eye was appeared three weeks ago, when he 
wake up in the morning. He had any symptoms else 
such as flu like symptoms, redness, conjunctivitis and 
fever. 
In clinical investigation weep was negative in his eye 
 
 
Figure 1. CMV retinitis at baseline 
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and movement was normal. He visited to shahid-
saddoghi-Hospital in Yazd province where he was 
treated with pulse of Prednisolone and Celcept for 
Behcet’s disease. He was refered to shahid-
labbafinejad-Hospital in Tehran. 
In his past medical history there was no similar 
disease: such as human immunodeficiency virus 
(HIV) or another diseases, only recurrent mouth 
Aftus was positive, drug history, allergy and family 
history were negative, physical exam items was BP = 
110/70 PR = 82 RR = 16 OT = 36.7˚C, Ocular 
movement was normal, visual acuity: Left eye: finger 
count, Right eye: normal, eye nedness after 
intravitreal injection was positive, dermathomal  
pathergy test was negative, ophthalmologist fundus 
copy report was: Macula Edema, peripheral 
hemorrhage, Macula lesion preferred CMV-Retinitis.  
He was treated with Ganciclovir 375mg/IV/Bd and 
Ganciclovir 200µg intravitreal for 2 weeks. His 
visual acuity improved from 1/10 to 3/10 during the 
treatment. He was also treated with treated with 
Valganciclovir 900mg/po/BD for 12 weeks and 




Cytomegalovirus infection is common5 (40% - 100% 
worldwide is seropositive). Cytomegalovirus retinitis 
is the most common opportunistic viral infection 
among HIV patients (30%)6, It occurs usually as 
CD4> 50/mm37. It is also seen in 
immunocompromised patients like ALL, organ 
transplant, corticosteroid therapy8. The disease is rare 
among immunocompetent patients (only nine case 
 
 
















Figure 6. Fundus view after 6sessions of intravitreal 
gancyclovir in 2 weeks  
 
A Young Immunocompetent Cytomegalovirus Retinitis Patient                                                                    Naseri et al. 
NBM 37  Novelty in Biomedicine 2019, 1, 35-7 
reported)9. 
The most common differential diagnosis of CMVR 
are VZV- Retinitis, HSV-Retinitis, toxoplasma- 
chorioretinitis, Behcat’s disease10. Potent drugs for 
treatment of CMVR are Ganciclivir, Val- 
Ganciclovir, foscarnet, cidofovir11. In the present 
investigation, he was as well as treated with 
Ganciclovir 375 mg/IV/BD 2 weeks and Ganciclovir 
intraviteral 200 µg + doses during 2 weeks. His 
visual acuity improved from 1/10 to 3/10 during 
treatment. 
Conclusion 
We Suggest in retinal vasculitis before approaching 
anti-inflammatory or another therapy, 
ophthalmologists should exclude infectious causes 
such as CMV retinitis. 
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Table 1: Patient Lab Tests 
FBS = [0]              BiL.T = 0.8             AST = 19           Na = 139       WBC = 7500 
Urea = 36             biL.D = 0.2            ALT = 34            K = 4.3           EOS = 2% 
Cr = 1.36              LTIV-Ab -             ALP = 179         ESR = 13         PLT = 157000 
HB = 15.1           HLA-B51 (Behcat’s test): negative - 
 
 
 Table 2: Viral Markers 
Serum CMV-PCR : Negative –  
CMV-PCR-Viterous: positive + 
HSV-PCR-Viterous: negative – 
VZV-PCR-Viterous: negative – 
 
 
